Your browser doesn't support javascript.
loading
Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome.
Yamato, Genki; Deguchi, Takao; Terui, Kiminori; Toki, Tsutomu; Watanabe, Tomoyuki; Imaizumi, Takahiro; Hama, Asahito; Iwamoto, Shotaro; Hasegawa, Daisuke; Ueda, Takahiro; Yokosuka, Tomoko; Tanaka, Shiro; Yanagisawa, Ryu; Koh, Katsuyoshi; Saito, Akiko M; Horibe, Keizo; Hayashi, Yasuhide; Adachi, Souichi; Mizutani, Shuki; Taga, Takashi; Ito, Etsuro; Watanabe, Kenichiro; Muramatsu, Hideki.
Afiliação
  • Yamato G; Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan.
  • Deguchi T; Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Terui K; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Toki T; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Watanabe T; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Imaizumi T; Department of Nutritional Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Aichi, Japan.
  • Hama A; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Iwamoto S; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Hasegawa D; Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan.
  • Ueda T; Department of Pediatrics, St Luke's International Hospital, Tokyo, Japan.
  • Yokosuka T; Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
  • Tanaka S; Department of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan.
  • Yanagisawa R; Clinical Biostatistics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Koh K; Department of Hematology and Oncology, Nagano Children's Hospital, Nagano, Japan.
  • Saito AM; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Hayashi Y; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Adachi S; Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan.
  • Mizutani S; Institute of Physiology and Medicine, Jobu University, Gunma, Japan.
  • Taga T; Department of Human Health Sciences, Kyoto University, Kyoto, Japan.
  • Ito E; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Watanabe K; Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
  • Muramatsu H; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Leukemia ; 35(5): 1480-1484, 2021 05.
Article em En | MEDLINE | ID: mdl-33654203

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Síndrome de Down / Mielopoese / Reação Leucemoide Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Síndrome de Down / Mielopoese / Reação Leucemoide Idioma: En Ano de publicação: 2021 Tipo de documento: Article